| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/22/2011 | US20110230561 Medical adhesive compositions |
| 09/22/2011 | US20110230550 Compounds, compositions and methods |
| 09/22/2011 | US20110230544 Modulation of c-reactive protein expression |
| 09/22/2011 | US20110230533 Imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use |
| 09/22/2011 | US20110230521 Pyrazole Compounds As CCR1 Antagonists |
| 09/22/2011 | US20110230518 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis |
| 09/22/2011 | US20110230516 CCR1 Antagonists and Methods of Use Therefor |
| 09/22/2011 | US20110230512 Pharmaceutical Composition |
| 09/22/2011 | US20110230511 Carboxamide bioisosteres of opiates |
| 09/22/2011 | US20110230504 ALLEVIATING DISORDERS WITH COMBINING AGENTS THAT INCREASE EPOXYGENATED FATTY ACIDS AND AGENTS THAT INCREASE cAMP |
| 09/22/2011 | US20110230503 6, 9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions |
| 09/22/2011 | US20110230494 Heteroaryl compounds and uses thereof |
| 09/22/2011 | US20110230493 1-OXA-8-Azaspiro [4,5] Decabe-8-Carboxamide Compounds as FAAH Inhibitors |
| 09/22/2011 | US20110230490 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 09/22/2011 | US20110230485 6-phenyl-pyrimidin-4-yl-(phenylamine or phenoxy) derivatives useful as modulators of nicotinic acetylcholine receptors |
| 09/22/2011 | US20110230484 Pyrazolyl-pyrimidine derivatives and their use as potassium channel modulators |
| 09/22/2011 | US20110230483 Pyridine and Pyrazine derivative for the Treatment of CF |
| 09/22/2011 | US20110230474 Topical antimicrobial compositions and methods of using same |
| 09/22/2011 | US20110230472 Ring-fused azole derivative having pi3k-inhibiting activity |
| 09/22/2011 | US20110230470 Substituted pyrazolo[4,3-c]pyridine derivatives active as kinase inhibitors |
| 09/22/2011 | US20110230464 Purine derivatives useful as p13 kinase inhibitors |
| 09/22/2011 | US20110230463 2h-chromene compound and derivative thereof |
| 09/22/2011 | US20110230462 Pyrrolopyrazine Kinase Inhibitors |
| 09/22/2011 | US20110230458 Phenyl-heteroaryl derivatives and methods of use thereof |
| 09/22/2011 | US20110230454 (aza)indole derivative and use thereof for medical purposes |
| 09/22/2011 | US20110230450 Platelet-activating factor (paf) analogs and uses thereof |
| 09/22/2011 | US20110230448 Treatment and/or Prevention of Non-Viral Epithelial Damage |
| 09/22/2011 | US20110230446 Cathepsin cysteine protease inhibitors |
| 09/22/2011 | US20110230443 IMIDAZO[1,2-a] PYRIDINYL BISPHOSPHONATES |
| 09/22/2011 | US20110230440 Inhibitors of fatty acid amide hydrolase |
| 09/22/2011 | US20110230431 Fosfomycin/tobramycin combinations for the treatment and prevention of ophthalmic, otological and dermatological infections |
| 09/22/2011 | US20110230426 Template-fixed peptidomimetics |
| 09/22/2011 | US20110230417 Treatment of diseases and conditions mediated by increased phosphorylation |
| 09/22/2011 | US20110230416 Peptide derivatives and use thereof as carriers for molecules in the form of conjugates |
| 09/22/2011 | US20110230414 Pyrrolopyrazine Kinase Inhibitors |
| 09/22/2011 | US20110230410 LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY |
| 09/22/2011 | US20110230397 Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer |
| 09/22/2011 | US20110229944 FAD4, FAD5, FAD5-2, AND FAD6, Novel Fatty Acid Desaturase Family Members and Uses Thereof |
| 09/22/2011 | US20110229584 Compound for the control of herpes simplex virus using glycyrrhizic acid, lipoic acid, allantoin, and slippery elm |
| 09/22/2011 | US20110229583 Human Medicinal Treatment Typically Using Salt of Peroxymonosulfuric Acid |
| 09/22/2011 | US20110229581 Releasable cationic lipids for nucleic acids delivery systems |
| 09/22/2011 | US20110229574 Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation |
| 09/22/2011 | US20110229573 Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form |
| 09/22/2011 | US20110229565 Drug Delivery Composition Comprising a Self-Assembled Gelator |
| 09/22/2011 | US20110229551 Drug delivery compositions and methods using nanofiber webs |
| 09/22/2011 | US20110229539 Chewing gum possessing tooth cleaning effect and a teeth cleaning method |
| 09/22/2011 | US20110229538 Topical skin care composition |
| 09/22/2011 | US20110229534 Non-Irritating Oral Care Formulations |
| 09/22/2011 | US20110229533 Extended release dosage form |
| 09/22/2011 | US20110229532 Process for nanoemulsification of curcumin and derivatives of curcumin |
| 09/22/2011 | US20110229530 Pharmaceutical dosage forms for time-specific drug delivery |
| 09/22/2011 | US20110229526 Formulations of nonopioid and confined opioid analgesics |
| 09/22/2011 | US20110229525 Modulation of cytokine signaling |
| 09/22/2011 | US20110229501 Organic compounds |
| 09/22/2011 | US20110229500 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 09/22/2011 | US20110229496 Method for regulating survival and memory of t helper 1 cells |
| 09/22/2011 | US20110229490 Lyophilized Formulations of Engineered Anti-IL-23p19 Antibodies |
| 09/22/2011 | US20110229486 Monoclonal Antibodies Against NKG2A |
| 09/22/2011 | US20110229476 Monospecific and multispecific antibodies and method of use |
| 09/22/2011 | US20110229475 Novel compounds |
| 09/22/2011 | US20110229471 Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease |
| 09/22/2011 | US20110229466 Vascular endothelial growth factor 2 |
| 09/22/2011 | US20110229465 Composition for treating disease |
| 09/22/2011 | US20110229460 anti-cd137 antibody as an agent in the treatment of inflammatory conditions |
| 09/22/2011 | US20110229459 Anti-nr10 antibody and use thereof |
| 09/22/2011 | US20110229436 Methods for reducing the likelihood of spontaneous abortion during assisted reproduction in a subject |
| 09/22/2011 | US20110229435 Expression and purification of hip/pap and uses therefor |
| 09/22/2011 | US20110229434 Uses of mammalian cytokine; related reagents |
| 09/22/2011 | US20110229423 Pacap signaling pathway modulators for treating inflammatory skin diseases having a neurogenic component, notably rosacea, and compositions comprised thereof |
| 09/22/2011 | US20110229409 Linkable lewis x analogs |
| 09/22/2011 | CA2793170A1 Aerosolized dapsone as a therapy for inflammation of the airway and abnormal mucociliary transport |
| 09/22/2011 | CA2793024A1 Imidazopyridine compounds, compositions and methods of use |
| 09/22/2011 | CA2792857A1 Topical skin care composition |
| 09/21/2011 | EP2366774A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366773A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366772A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366771A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366702A1 New oxadiazole derivatives |
| 09/21/2011 | EP2366699A1 8-substituted isoquinoline derivative and use thereof |
| 09/21/2011 | EP2366405A2 IL-17 antagonistic antibodies |
| 09/21/2011 | EP2366394A1 Characterization and validation of inhibitors and ligands of dipeptidyl aminopeptidase IV (DP IV) |
| 09/21/2011 | EP2366391A2 Anti-inflammatory agents |
| 09/21/2011 | EP2366390A2 Anti-inflammatory agents |
| 09/21/2011 | EP2366389A1 Severe sepsis preventive therapeutic agent |
| 09/21/2011 | EP2365813A2 Methods of reducing the risk of cardiovascular disease in postmenopausal women |
| 09/21/2011 | EP2365749A1 Quinolone neuropeptide s receptor antagonists |
| 09/21/2011 | EP2215082B1 Phthalazine and pyrido[3,4-d]pyridazine compounds as h1 receptor antagonists |
| 09/21/2011 | EP2155683B8 Pyridone derivatives as p38a mapk inhibitors |
| 09/21/2011 | EP2104510B1 Use of at least one botulism neurotoxin for treating the pain induced by therapeutic treatments for the aids virus |
| 09/21/2011 | EP1896424B1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |
| 09/21/2011 | EP1751171B1 Novel galactoside inhibitors of galectins |
| 09/21/2011 | EP1720551B9 Alkaloid formulations |
| 09/21/2011 | EP1519956B1 Epha2 monoclonal antibodies and methods of use thereof |
| 09/21/2011 | EP1492811B1 Muteins of the c5a anaphylatoxin, nucleic acid molecules encoding such muteins, and pharmaceutical uses of muteins of the c5a anaphylatoxin |
| 09/21/2011 | EP1436298B1 Himbacine analogues as thrombin receptor antagonists |
| 09/21/2011 | EP1341546B1 Kyberdrug as autovaccines with immune-regulating effects |
| 09/21/2011 | EP0954303B1 Methods of treating mental diseases, inflammation and pain |
| 09/21/2011 | CN201977364U 一种中草药枕芯 One kind of herbal pillow |
| 09/21/2011 | CN1943724B A Chinese traditional medicinal composition for treatment of migraine and its preparation method |
| 09/21/2011 | CN1923263B Traditional Chinese medicine composition, its preparing method and quality controlling means |